Panacea Biotec Limited has announced the closure of its trading window for all designated persons and their immediate relatives. This closure will be effective from January 01, 2026, and will remain in place until 48 hours after the announcement of the company's unaudited financial results for the quarter and nine months ending December 31, 2025. The company will inform the stock exchanges in due course about the date of the Board of Directors' meeting to approve these financial results. This intimation is in accordance with the Company's Code of Conduct for Prevention of Insider Trading, framed under SEBI (Prohibition of Insider Trading) Regulations, 2015.
